facebook
twitter
rss
account
search
search
 

Malaria drug may help boost cancer therapy

Feb. 21, 2012 at 8:56 PM   |   Comments

VANCOUVER, British Columbia, Feb. 21 (UPI) -- Blocking autophagy -- the process of "self-eating" within cells -- might be a viable way to enhance cancer treatment effectiveness, U.S. researchers said.

Dr. Ravi K. Amaravadi, an assistant professor at the Perelman School of Medicine and Abramson Cancer Center at the University of Pennsylvania, and his laboratory demonstrated adding hydroxychloroquine -- a Food and Drug Administration-approved drug used commonly for malaria and rheumatoid arthritis -- to many cancer therapies, including chemotherapy, targeted therapy, radiation and immunotherapy.

It can enhance the anti-tumor activity of these drugs in laboratory models of treatment-resistant cancers and ongoing clinical trials, Amaravadi said.

Autophagy is increased in cancer cells -- normally, it is a survival pathway allowing a cell to recycle damaged proteins when it's under stress and reuse the damaged parts to fuel further growth.

However, cancer cells might be addicted to autophagy, since this innate response may be a critical means by which the cells survive nutrient limitation and lack of oxygen commonly found within tumors. It might explain how some cancer cells evade chemotherapies, the study said.

Nearly 30 Phase I and Phase II clinical trials involving hydroxychloroquine have begun or are in the planning stages in many different malignancies, including melanoma, multiple myeloma, renal cell carcinoma, colon cancer, prostate cancer and breast cancer, Amaravadi said.

The findings were presented at the annual American Association for Advancement of Science meeting in Vancouver.

Topics: Phase II
© 2012 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Most Popular
1
Vast majority of oncologists admit to burnout Vast majority of oncologists admit to burnout
2
Study: Drug cocktail for advanced breast cancer can extend life up to 16 months Study: Drug cocktail for advanced breast cancer can extend life up to 16 months
3
France considers plain cigarette packaging France considers plain cigarette packaging
4
Morning exercise helps calm ADHD symptoms in children Morning exercise helps calm ADHD symptoms in children
5
CDC: Diabetes rates leveling off CDC: Diabetes rates leveling off
Trending News
x
Feedback